Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 1, 2007, Pages

  He, Jeff Z ^a,b   Quan, Adrian ^a   Xu, Yi ^c   Teoh, Hwee ^a   Wang, Guilin ^a   Fish, Jason E ^a   Steer, Brent M ^a   Itohara, Shigeyoshi ^d   Marsden, Philip A ^a   Davidge, Sandra T ^c   Ward, Michael E ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Endothelin; Endothelium; Vascular remodeling; Vascular smooth muscle

Indexed keywords

BIG ENDOTHELIN 1; CYSTEINE DERIVATIVE; CYSTEINYLTHREONYLTHREONYLHISTIDYLTRYPTOPHYLGLYCYLPHENYLALANYLTHREONYLLEUCYLCYSTEIN; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANOXIA; ARTERIES; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 33846221142     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00538.2006     Document Type: Article

References (49)

1. Auer G, Ward ME. Impaired reactivity of rat aorta to phenylephrine and KCl after prolonged hypoxia: role of the endothelium. J Appl Physiol 85: 411-417, 1998.
2. Bendeck MP, Keeley FW, Langille BL. Perinatal accumulation of arterial wall constituents: relation to hemodynamic changes at birth. Am J Physiol Heart Circ Physiol 267: H2268-H2279, 1994.
3. Bendeck MP, Langille BL. Changes in blood flow distribution during the perinatal period in fetal sheep and lambs. Can J Physiol Pharmacol 70: 1576-1582, 1992.
4. Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A. Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 90: 784-791, 2002.
5. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 369: 485-496, 2003.
6. Bjornheden T, Evaldsson M, Wiklund O. A method for the assessment of hypoxia in the arterial wall, with potential application in vivo. Arterioscler Thromb Vasc Biol 16: 178-185, 1996.
7. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207-214, 2002.
8. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol 42: 228-234, 1977.
9. 2 extraction by canine hindlimb during α-adrenergic blockade and hypoxic hypoxia. J Appl Physiol 48: 630-635, 1980.
10. Canning MT, Postovit LM, Clarke SH, Graham CH. Oxygen-mediated regulation of gelatinase and tissue inhibitor of metalloproteinases-1 expression by invasive cells. Exp Cell Res 267: 88-94, 2001.
11. Chen PS, Zhai WR, Zhou XM, Zhang JS, Zhang YE, Ling YQ, Gu YH. Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells. World J Gastroenterol 7: 647-651, 2001.
12. Deschamps AM, Yarbrough WM, Squires CE, Allen RA, McClister DM, Dowdy KB, McLean JE, Mingoia JT, Sample JA, Mukherjee R, Spinale FG. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity. Circulation 111: 1166-1174, 2005.
13. Fahling M, Perlewitz A, Doller A, Thiele BJ. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia. Comp Biochem Physiol C Toxicol Pharmacol 139: 119-126, 2004.
14. Fernandez-Patron C, Radomski MW, Davidge ST. Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol 278: H1473-H1479, 2000.
15. Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves Big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85: 906-911, 1999.
16. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87: 670-676, 2000.
17. Govindaraju V, Teoh H, Hamid Q, Cernacek P, Ward ME. Interaction between endothelial heme oxygenase-2 and endothelin-1 in altered aortic reactivity after hypoxia in rats. Am J Physiol Heart Circ Physiol 288: H962-H970, 2005.
18. Hao L, Du M, Lopez-Campistrous A, and Fernandez-Patron C. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ Res 94: 68-76, 2004.
19. Heistad DD, Wheeler RC, Aoki VS. Reflex cardiovascular responses after 36 hr of hypoxia. Am J Physiol 220: 1673-1676, 1971.
20. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272: 22389-22392, 1997.
21. Jeyabalan A, Novak J, Danielson LA, Kerchner LJ, Opett SL, and Conrad KP. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res 93: 1249-1257, 2003.
22. Johnson GD, Ahn K. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1. Anal Biochem 286: 112-118, 2000.
23. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, Azar DT. Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508: 187-190, 2001.
24. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 296: 263-266, 1992.
25. Kondo S, Kubota S, Shimo T, Nishida T, Yosimichi G, Eguchi T, Sugahara T, Takigawa M. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23: 769-776, 2002.
26. Kuwahira I, Gonzalez NC, Heisler N, Piiper J. Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats. J Appl Physiol 74: 211-214, 1993.
27. Lee M, Song SU, Ryu JK, Suh JK. Sp1-dependent regulation of the tissue inhibitor of metalloproteinases-1 promoter. J Cell Biochem 91: 1260-1268, 2004.
28. Lucchesi PA, Sabri A, Belmadani S, Matrougui K. Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110: 3587-3593, 2004.
29. Martinez A, Oh HR, Unsworth EJ, Bregonzio C, Saavedra JM, Stetler-Stevenson WG, Cuttitta F. Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator. Biochem J 383: 413-418, 2004.
30. Martinez-Lemus LA, Wu X, Wilson E, Hill MA, Davis GE, Davis MJ, Meininger GA. Integrins as unique receptors for vascular control. J Vasc Res 40: 211-233, 2003.
31. McMahon S, Grondin F, McDonald PP, Richard DE, Dubois CM. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J Biol Chem 280: 6561-6569, 2005.
32. Merchant S, Narumiya H, Zhang Y, Guilbert L, Davidge S. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 23: 47-60, 2004.
33. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351-2366, 2000.
34. Ottino P, Finley J, Rojo E, Ottlecz A, Lambrou GN, Bazan HEP, Bazan NG. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol Vis 10: 341-350, 2004.
35. Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G. Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24: 25-35, 2003.
36. Petrella BL, Lohi J, Brinckerhoff CE. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24: 1043-1052, 2005.
37. Richardson M, Hadcock SJ, DeReske M, Cybulsky MI. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb 14: 760-769, 1994.
38. Roland I, Minet E, Ernest I, Pascal T, Michel G, Remacle J, Michiels C. Identification of hypoxia-responsive messengers expressed in human microvascular endothelial cells using differential display RT-PCR. Eur J Biochem 267: 3567-3574, 2000.
39. Semenza GL. New insights into nNOS regulation of vascular homeostasis. J Clin Invest 115: 2976-2978, 2005.
40. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
41. Teoh H, Zacour M, Wener AD, Gunaratnam L, Ward ME. Increased myofibrillar protein phosphatase-1 activity impairs rat aortic smooth muscle activation after hypoxia. Am J Physiol Heart Circ Physiol 284: H1182-H1189, 2003.
42. Tretinyak AS, Lee ES, Uema KM, d'Audiffret AC, Caldwell MP, Santilli SM. Supplemental oxygen reduces intimal hyperplasia after intraarterial stenting in the rabbit. J Vasc Surg 35: 982-987, 2002.
43. Tsai AG, Friesenecker B, Mazzoni MC, Kerger H, Buerk DG, Johnson PC, Intaglietta M. Microvascular and tissue oxygen gradients in the rat mesentery. Proc Natl Acad Sci USA 95: 6590-6595, 1998.
44. Vieillard-Baron A, Frisdal E, Raffestin B, Baker AH, Eddahibi S, Adnot S, D'Ortho MP. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer limits monocrotaline-induced pulmonary vascular remodeling in rats. Hum Gene Ther 14: 861-869, 2003.
45. Wadsworth RM. Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol Sci 15: 47-53, 1994.
46. Ward ME. Dilation of rat diaphragmatic arterioles by flow and hypoxia: roles of nitric oxide and prostaglandins. J Appl Physiol 86: 1644-1650, 1999.
47. Ward ME, Toporsian M, Scott JA, Teoh H, Govindaraju V, Quan A, Wener AD, Wang G, Bevan SC, Newton DC, Marsden PA. Hypoxia induces a functionally significant and translationally efficient neuronal NO synthase mRNA variant. J Clin Invest 115: 3128-3139, 2005.
48. Zacour ME, Teoh H, Halayko AJ, Ward ME. Mechanisms of aortic smooth muscle hyporeactivity after prolonged hypoxia in rats. J Appl Physiol 92: 2625-2632, 2002.
49. Zacour ME, Toporsian M, Auer G, Cernacek P, Ward ME. Enhancement of aortic contractility by endothelin following prolonged hypoxia in vivo. Pulm Pharmacol Ther 11: 197-199, 1998.